Discounted Cash Flow (DCF) Analysis Levered

MiMedx Group, Inc. (MDXG)

$7.99

+0.22 (+2.83%)
All numbers are in Millions, Currency in USD
Stock DCF: -0.91 | 7.99 | overvalue

Free Cash Flow

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 359.11299.25248.23258.61267.84250.45234.19218.99204.77191.48
Revenue (%)
Operating Cash Flow 35.80-39.41-30.26-1.98-17.89-11.44-10.70-10-9.35-8.75
Operating Cash Flow (%)
Capital Expenditure -10.03-2.22-4.55-3.47-2.68-3.86-3.61-3.38-3.16-2.95
Capital Expenditure (%)
Free Cash Flow 25.77-41.63-34.82-5.45-20.58-15.30-14.31-13.38-12.51-11.70

Weighted Average Cost Of Capital

Share price $ 7.99
Beta 1.625
Diluted Shares Outstanding 112.91
Cost of Debt
Tax Rate -0.69
After-tax Cost of Debt 10.32%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.826
Total Debt 48.59
Total Equity 902.15
Total Capital 950.74
Debt Weighting 5.11
Equity Weighting 94.89
Wacc

Build Up Free Cash Flow

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Revenue 359.11299.25248.23258.61267.84250.45234.19218.99204.77191.48
Operating Cash Flow 35.80-39.41-30.26-1.98-17.89-11.44-10.70-10-9.35-8.75
Capital Expenditure -10.03-2.22-4.55-3.47-2.68-3.86-3.61-3.38-3.16-2.95
Free Cash Flow 25.77-41.63-34.82-5.45-20.58-15.30-14.31-13.38-12.51-11.70
WACC
PV LFCF -13.69-11.46-9.59-8.02-6.71
SUM PV LFCF -49.48

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 11.75
Free cash flow (t + 1) -11.93
Terminal Value -122.40
Present Value of Terminal Value -70.24

Intrinsic Value

Enterprise Value -119.72
Net Debt -17.36
Equity Value -102.36
Shares Outstanding 112.91
Equity Value Per Share -0.91